The DOI matches its Crossref record; 158 of the 158 references it cites were found in a registry or an index.
Biomarkers in Hepatocellular Carcinoma: Diagnosis, Prognosis and Treatment Response Assessment
Open accessAbstract
Hepatocellular carcinoma (HCC) is one of the main cancer-related causes of death worldwide. Thus, there is a constant search for improvement in screening, diagnosis, and treatment strategies to improve the prognosis of this malignancy. The identification of useful biomarkers for surveillance and early HCC diagnosis is still deficient, with available serum biomarkers showing low sensitivity and heterogeneous specificity despite different cut-off points, even when assessed longitudinally, or with a combination of serum biomarkers. In contrast, HCC biomarkers used for prognostic (when associated with clinical outcomes) or predictive purposes (when associated with treatment response) may have an increased clinical role in the near future. Furthermore, some serum biomarkers are already implicated as a treatment selection tool, whether to provide access to certain therapies or to assess clinical benefit after treatment. In the present review we will discuss the clinical utility and foreseen future of HCC biomarkers implicated in surveillance, diagnosis, prognosis, and post-treatment assessment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sorafenib in advanced hepatocellular carcinoma
Llovet, J. M., Ricci, S., Mazzaferro, V., Hilgard, P., Gane, E., Blanc, J.-F., de Oliveira, A. C., Santoro, A., Raoul, J.-L., Forner, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708857 · Cited by 13,097
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Galle, P. R., Forner, A., Llovet, J. M., Mazzaferro, V., Piscaglia, F., Raoul, J.-L., Schirmacher, P., & Vilgrain, V. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.019 · Cited by 11,406
Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma
Finn, R. S., Qin, S., Ikeda, M., Galle, P. R., Ducreux, M., Kim, T.-Y., Kudo, M., Breder, V., Merle, P., Kaseb, A. O., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1915745 · Cited by 7,470
Mazzaferro, V., Regalia, E., Doci, R., Andreola, S., Pulvirenti, A., Bozzetti, F., Montalto, F., Ammatuna, M., Morabito, A., & Gennari, L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603143341104 · Cited by 7,186
A New Era of Systemic Therapy for Hepatocellular Carcinoma with Regorafenib and Lenvatinib
Kudo, M. (2017) · Liver Cancer · doi:10.1159/000462153 · Cited by 5,936
Cheng, A.-L., Kang, Y.-K., Chen, Z., Tsao, C.-J., Qin, S., Kim, J. S., Luo, R., Feng, J., Ye, S., Yang, T.-S., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70285-7 · Cited by 5,832
Kudo, M., Finn, R. S., Qin, S., Han, K.-H., Ikeda, K., Piscaglia, F., Baron, A., Park, J.-W., Han, G., Jassem, J., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30207-1 · Cited by 5,497
Acute Abdomen: A Rare Case of Ruptured Hepatocellular Carcinoma
Gloor, S., Jensen, K. O., Breitenstein, S., Binkert, C. A., Angst, E., & Hetzer, F. H. (2017) · Case Reports in Gastroenterology · doi:10.1159/000463378 · Cited by 5,370
Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma
Lencioni, R., & Llovet, J. (2010) · Seminars in Liver Disease · doi:10.1055/s-0030-1247132 · Cited by 4,329
El-Khoueiry, A. B., Sangro, B., Yau, T., Crocenzi, T. S., Kudo, M., Hsu, C., Kim, T.-Y., Choo, S.-P., Trojan, J., Welling, T. H., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31046-2 · Cited by 4,280
A global view of hepatocellular carcinoma: trends, risk, prevention and management
Yang, J. D., Hainaut, P., Gores, G. J., Amadou, A., Plymoth, A., & Roberts, L. R. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0186-y · Cited by 4,228
AASLD guidelines for the treatment of hepatocellular carcinoma
Heimbach, J. K., Kulik, L. M., Finn, R. S., Sirlin, C. B., Abecassis, M. M., Roberts, L. R., Zhu, A. X., Murad, M. H., & Marrero, J. A. (2018) · Hepatology · doi:10.1002/hep.29086 · Cited by 4,070
Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification
Llovet, J., Brú, C., & Bruix, J. (1999) · Seminars in Liver Disease · doi:10.1055/s-2007-1007122 · Cited by 3,805
Bruix, J., Qin, S., Merle, P., Granito, A., Huang, Y.-H., Bodoky, G., Pracht, M., Yokosuka, O., Rosmorduc, O., Breder, V., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32453-9 · Cited by 3,653
Johnson, P. J., Berhane, S., Kagebayashi, C., Satomura, S., Teng, M., Reeves, H. L., O'Beirne, J., Fox, R., Skowronska, A., Palmer, D., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.57.9151 · Cited by 2,783
Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma
Ally, A., Balasundaram, M., Carlsen, R., Chuah, E., Clarke, A., Dhalla, N., Holt, R. A., Jones, S. J. M., Lee, D., Ma, Y., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.046 · Cited by 2,490
Zhu, A. X., Finn, R. S., Edeline, J., Cattan, S., Ogasawara, S., Palmer, D., Verslype, C., Zagonel, V., Fartoux, L., Vogel, A., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30351-6 · Cited by 2,479
Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
Abou-Alfa, G. K., Meyer, T., Cheng, A.-L., El-Khoueiry, A. B., Rimassa, L., Ryoo, B.-Y., Cicin, I., Merle, P., Chen, Y., Park, J.-W., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1717002 · Cited by 2,344
Omata, M., Cheng, A.-L., Kokudo, N., Kudo, M., Lee, J. M., Jia, J., Tateishi, R., Han, K.-H., Chawla, Y. K., Shiina, S., et al. (2017) · Hepatology International · doi:10.1007/s12072-017-9799-9 · Cited by 2,171
Global Burden of Disease Liver Cancer Collaboration, Akinyemiju, T., Abera, S., Ahmed, M., Alam, N., Alemayohu, M. A., Allen, C., Al-Raddadi, R., Alvis-Guzman, N., Amoako, Y., et al. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2017.3055 · Cited by 1,987
Molecular therapies and precision medicine for hepatocellular carcinoma
Llovet, J. M., Montal, R., Sia, D., & Finn, R. S. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0073-4 · Cited by 1,938
Finn, R. S., Ryoo, B.-Y., Merle, P., Kudo, M., Bouattour, M., Lim, H. Y., Breder, V., Edeline, J., Chao, Y., Ogasawara, S., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.19.01307 · Cited by 1,789
Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma
Bruix, J., Reig, M., & Sherman, M. (2016) · Gastroenterology · doi:10.1053/j.gastro.2015.12.041 · Cited by 1,694
Phases of Biomarker Development for Early Detection of Cancer
Pepe, M. S., Etzioni, R., Feng, Z., Potter, J. D., Thompson, M. L., Thornquist, M., Winget, M., & Yasui, Y. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.14.1054 · Cited by 1,686
Zhu, A. X., Kang, Y.-K., Yen, C.-J., Finn, R. S., Galle, P. R., Llovet, J. M., Assenat, E., Brandi, G., Pracht, M., Lim, H. Y., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30937-9 · Cited by 1,662
Randomized controlled trial of screening for hepatocellular carcinoma
Zhang, B.-H., Yang, B.-H., & Tang, Z.-Y. (2004) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-004-0552-0 · Cited by 1,496
Nagy, Á., Lánczky, A., Menyhárt, O., & Győrffy, B. (2018) · Scientific Reports · doi:10.1038/s41598-018-27521-y · Cited by 1,319
A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients
(1998) · Hepatology · doi:10.1002/hep.510280322 · Cited by 1,238
Tzartzeva, K., Obi, J., Rich, N. E., Parikh, N. D., Marrero, J. A., Yopp, A., Waljee, A. K., & Singal, A. G. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.01.064 · Cited by 1,207
Sangro, B., Gomez-Martin, C., de la Mata, M., Iñarrairaegui, M., Garralda, E., Barrera, P., Riezu-Boj, J. I., Larrea, E., Alfaro, C., Sarobe, P., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.02.022 · Cited by 980
Duvoux, C., Roudot–Thoraval, F., Decaens, T., Pessione, F., Badran, H., Piardi, T., Francoz, C., Compagnon, P., Vanlemmens, C., Dumortier, J., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.05.052 · Cited by 955
SINGAL, A., VOLK, M. L., WALJEE, A., SALGIA, R., HIGGINS, P., ROGERS, M. A. M., & MARRERO, J. A. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2009.04014.x · Cited by 819
Cheng, A.-L., Kang, Y.-K., Lin, D.-Y., Park, J.-W., Kudo, M., Qin, S., Chung, H.-C., Song, X., Xu, J., Poggi, G., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.8372 · Cited by 777
Johnson, P. J., Qin, S., Park, J.-W., Poon, R. T. P., Raoul, J.-L., Philip, P. A., Hsu, C.-H., Hu, T.-H., Heo, J., Xu, J., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.48.4410 · Cited by 772
Ren, Z., Li, A., Jiang, J., Zhou, L., Yu, Z., Lu, H., Xie, H., Chen, X., Shao, L., Zhang, R., et al. (2019) · Gut · doi:10.1136/gutjnl-2017-315084 · Cited by 764
Marrero, J. A., Feng, Z., Wang, Y., Nguyen, M. H., Befeler, A. S., Roberts, L. R., Reddy, K. R., Harnois, D., Llovet, J. M., Normolle, D., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.04.005 · Cited by 745
Trevisani, F., D'Intino, P. E., Morselli-Labate, A. M., Mazzella, G., Accogli, E., Caraceni, P., Domenicali, M., De Notariis, S., Roda, E., & Bernardi, M. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(00)00053-2 · Cited by 731
Kudo, M., Chung, H., & Osaki, Y. (2003) · Journal of Gastroenterology · doi:10.1007/s005350300038 · Cited by 700
Yau, T., Tang, V. Y. F., Yao, T.-J., Fan, S.-T., Lo, C.-M., & Poon, R. T. P. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.02.032 · Cited by 698
Identification of metastasis-related microRNAs in hepatocellular carcinoma
Budhu, A., Jia, H.-L., Forgues, M., Liu, C.-G., Goldstein, D., Lam, A., Zanetti, K. A., Ye, Q.-H., Qin, L.-X., Croce, C. M., et al. (2008) · Hepatology · doi:10.1002/hep.22160 · Cited by 697
Lencioni, R., Llovet, J. M., Han, G., Tak, W. Y., Yang, J., Guglielmi, A., Paik, S. W., Reig, M., Kim, D. Y., Chau, G.-Y., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.01.012 · Cited by 694
Mazzaferro, V., Sposito, C., Zhou, J., Pinna, A. D., De Carlis, L., Fan, J., Cescon, M., Di Sandro, S., Yi-feng, H., Lauterio, A., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2017.09.025 · Cited by 655
Lok, A. S., Seeff, L. B., Morgan, T. R., di Bisceglie, A. M., Sterling, R. K., Curto, T. M., Everson, G. T., Lindsay, K. L., Lee, W. M., Bonkovsky, H. L., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.09.014 · Cited by 651
Plasma MicroRNA Panel to Diagnose Hepatitis B Virus–Related Hepatocellular Carcinoma
Zhou, J., Yu, L., Gao, X., Hu, J., Wang, J., Dai, Z., Wang, J.-F., Zhang, Z., Lu, S., Huang, X., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.2697 · Cited by 635
Cainap, C., Qin, S., Huang, W.-T., Chung, I. J., Pan, H., Cheng, Y., Kudo, M., Kang, Y.-K., Chen, P.-J., Toh, H.-C., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2013.54.3298 · Cited by 629
Biology and significance of alpha-fetoprotein in hepatocellular carcinoma
Galle, P. R., Foerster, F., Kudo, M., Chan, S. L., Llovet, J. M., Qin, S., Schelman, W. R., Chintharlapalli, S., Abada, P. B., Sherman, M., et al. (2019) · Liver International · doi:10.1111/liv.14223 · Cited by 597
Leung, T. W. T., Tang, A. M. Y., Zee, B., Lau, W. Y., Lai, P. B. S., Leung, K. L., Lau, J. T. F., Yu, S. C. H., & Johnson, P. J. (2002) · Cancer · doi:10.1002/cncr.10384 · Cited by 583
Zhu, A. X., Rosmorduc, O., Evans, T. R. J., Ross, P. J., Santoro, A., Carrilho, F. J., Bruix, J., Qin, S., Thuluvath, P. J., Llovet, J. M., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2013.53.7746 · Cited by 576
Bruix, J., Cheng, A.-L., Meinhardt, G., Nakajima, K., De Sanctis, Y., & Llovet, J. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.06.026 · Cited by 562
Plasma Biomarkers as Predictors of Outcome in Patients with Advanced Hepatocellular Carcinoma
Llovet, J. M., Peña, C. E. A., Lathia, C. D., Shan, M., Meinhardt, G., & Bruix, J. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2175 · Cited by 559
Papatheodoridis, G., Dalekos, G., Sypsa, V., Yurdaydin, C., Buti, M., Goulis, J., Calleja, J. L., Chi, H., Manolakopoulos, S., Mangia, G., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.035 · Cited by 557
Santoro, A., Rimassa, L., Borbath, I., Daniele, B., Salvagni, S., Van Laethem, J. L., Van Vlierberghe, H., Trojan, J., Kolligs, F. T., Weiss, A., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70490-4 · Cited by 554
Competing risks and prognostic stages of cirrhosis: a 25‐year inception cohort study of 494 patients
D'Amico, G., Pasta, L., Morabito, A., D'Amico, M., Caltagirone, M., Malizia, G., Tinè, F., Giannuoli, G., Traina, M., Vizzini, G., et al. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12721 · Cited by 547
A new prognostic classification for predicting survival in patients with hepatocellular carcinoma
Chevret, S., Trinchet, J.-C., Mathieu, D., Rached, A. A., Beaugrand, M., & Chastang, C. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80173-1 · Cited by 512
Mitchell, D. G., Bruix, J., Sherman, M., & Sirlin, C. B. (2015) · Hepatology · doi:10.1002/hep.27304 · Cited by 484
Predictive markers of anti-VEGF and emerging role of angiogenesis inhibitors as immunotherapeutics
Hegde, P. S., Wallin, J. J., & Mancao, C. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.12.002 · Cited by 453
Villanueva, A., Hoshida, Y., Battiston, C., Tovar, V., Sia, D., Alsinet, C., Cornella, H., Liberzon, A., Kobayashi, M., Kumada, H., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.02.006 · Cited by 447
Trinchet, J.-C., Chaffaut, C., Bourcier, V., Degos, F., Henrion, J., Fontaine, H., Roulot, D., Mallat, A., Hillaire, S., Cales, P., et al. (2010) · Hepatology · doi:10.1002/hep.24545 · Cited by 400
Shen, Q., Fan, J., Yang, X.-R., Tan, Y., Zhao, W., Xu, Y., Wang, N., Niu, Y., Wu, Z., Zhou, J., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70233-4 · Cited by 394
Diagnosis and staging of hepatocellular carcinoma (HCC): current guidelines
Ayuso, C., Rimola, J., Vilana, R., Burrel, M., Darnell, A., García-Criado, Á., Bianchi, L., Belmonte, E., Caparroz, C., Barrufet, M., et al. (2018) · European Journal of Radiology · doi:10.1016/j.ejrad.2018.01.025 · Cited by 394
Marrero, J. A., Su, G. L., Wei, W., Emick, D., Conjeevaram, H. S., Fontana, R. J., & Lok, A. S. (2003) · Hepatology · doi:10.1053/jhep.2003.50195 · Cited by 387
GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma
Marrero, J. A., Romano, P. R., Nikolaeva, O., Steel, L., Mehta, A., Fimmel, C. J., Comunale, M. A., D'Amelio, A., Lok, A. S., & Block, T. M. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.05.028 · Cited by 364
The Use and Interpretation of Competing Risks Regression Models
Dignam, J. J., Zhang, Q., & Kocherginsky, M. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2097 · Cited by 357
Sherman, M., Peltekian, K. M., & Lee, C. (1995) · Hepatology · doi:10.1002/hep.1840220210 · Cited by 357
Kudo, M., Chung, H., Haji, S., Osaki, Y., Oka, H., Seki, T., Kasugai, H., Sasaki, Y., & Matsunaga, T. (2004) · Hepatology · doi:10.1002/hep.20486 · Cited by 353
Rimassa, L., Assenat, E., Peck-Radosavljevic, M., Pracht, M., Zagonel, V., Mathurin, P., Rota Caremoli, E., Porta, C., Daniele, B., Bolondi, L., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30146-3 · Cited by 351
Serum alpha-fetoprotein levels in patients with advanced hepatitis C: Results from the HALT-C Trial
Di Bisceglie, A. M., Sterling, R. K., Chung, R. T., Everhart, J. E., Dienstag, J. L., Bonkovsky, H. L., Wright, E. C., Everson, G. T., Lindsay, K. L., Lok, A. S. F., et al. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.03.019 · Cited by 350
Johnson, P. J., Pirrie, S. J., Cox, T. F., Berhane, S., Teng, M., Palmer, D., Morse, J., Hull, D., Patman, G., Kagebayashi, C., et al. (2014) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-0870 · Cited by 350
Ahn, J. C., Teng, P., Chen, P., Posadas, E., Tseng, H., Lu, S. C., & Yang, J. D. (2021) · Hepatology · doi:10.1002/hep.31165 · Cited by 338
Toso, C., Asthana, S., Bigam, D. L., Shapiro, A. M. J., & Kneteman, N. M. (2009) · Hepatology · doi:10.1002/hep.22693 · Cited by 332
Poté, N., Cauchy, F., Albuquerque, M., Voitot, H., Belghiti, J., Castera, L., Puy, H., Bedossa, P., & Paradis, V. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.11.005 · Cited by 328
Pinyol, R., Montal, R., Bassaganyas, L., Sia, D., Takayama, T., Chau, G.-Y., Mazzaferro, V., Roayaie, S., Lee, H. C., Kokudo, N., et al. (2019) · Gut · doi:10.1136/gutjnl-2018-316408 · Cited by 326
Molecular therapies for HCC: Looking outside the box
Faivre, S., Rimassa, L., & Finn, R. S. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.09.010 · Cited by 326
Berhane, S., Toyoda, H., Tada, T., Kumada, T., Kagebayashi, C., Satomura, S., Schweitzer, N., Vogel, A., Manns, M. P., Benckert, J., et al. (2016) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.12.042 · Cited by 323
Tang, A., Bashir, M. R., Corwin, M. T., Cruite, I., Dietrich, C. F., Do, R. K. G., Ehman, E. C., Fowler, K. J., Hussain, H. K., Jha, R. C., et al. (2018) · Radiology · doi:10.1148/radiol.2017170554 · Cited by 319
Screening for liver cancer: results of a randomised controlled trial in Qidong, China
Chen, J.-G., Parkin, D. M., Chen, Q.-G., Lu, J.-H., Shen, Q.-J., Zhang, B.-C., & Zhu, Y.-R. (2003) · Journal of Medical Screening · doi:10.1258/096914103771773320 · Cited by 312
Santi, V., Trevisani, F., Gramenzi, A., Grignaschi, A., Mirici-Cappa, F., Poggio, P. D., Nolfo, M. A. D., Benvegnù, L., Farinati, F., Zoli, M., et al. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.03.010 · Cited by 304
Hippo, Y., Watanabe, K., Watanabe, A., Midorikawa, Y., Yamamoto, S., Ihara, S., Tokita, S., Iwanari, H., Ito, Y., Nakano, K., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2191 · Cited by 297
A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation
Yao, F. Y., Hirose, R., LaBerge, J. M., Davern, T. J., Bass, N. M., Kerlan, R. K., Merriman, R., Feng, S., Freise, C. E., Ascher, N. L., et al. (2005) · Liver Transplantation · doi:10.1002/lt.20526 · Cited by 288
Best, J., Bechmann, L. P., Sowa, J.-P., Sydor, S., Dechêne, A., Pflanz, K., Bedreli, S., Schotten, C., Geier, A., Berg, T., et al. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.11.012 · Cited by 288
Hameed, B., Mehta, N., Sapisochin, G., Roberts, J. P., & Yao, F. Y. (2014) · Liver Transplantation · doi:10.1002/lt.23904 · Cited by 279
Duffy, S. W., Nagtegaal, I. D., Wallis, M., Cafferty, F. H., Houssami, N., Warwick, J., Allgood, P. C., Kearins, O., Tappenden, N., O'Sullivan, E., et al. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn120 · Cited by 279
Liver transplantation for hepatocellular carcinoma beyond the Milan criteria
Xu, X., Lu, D., Ling, Q., Wei, X., Wu, J., Zhou, L., Yan, S., Wu, L., Geng, L., Ke, Q., et al. (2016) · Gut · doi:10.1136/gutjnl-2014-308513 · Cited by 275
Harnois, D. (2009) · Yearbook of Gastroenterology · doi:10.1016/s0739-5930(09)79363-8 · Cited by 268
Nivolumab in advanced hepatocellular carcinoma: Sorafenib-experienced Asian cohort analysis
Yau, T., Hsu, C., Kim, T.-Y., Choo, S.-P., Kang, Y.-K., Hou, M.-M., Numata, K., Yeo, W., Chopra, A., Ikeda, M., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.05.014 · Cited by 267
Atiq, O., Tiro, J., Yopp, A. C., Muffler, A., Marrero, J. A., Parikh, N. D., Murphy, C., McCallister, K., & Singal, A. G. (2017) · Hepatology · doi:10.1002/hep.28895 · Cited by 266
Pan, H., Ou, Y., Peng, S., Liu, S., Lai, P., Lee, P., Sheu, J., Chen, C., & Hsu, H. (2003) · Cancer · doi:10.1002/cncr.11487 · Cited by 251
Yang, J. D., Addissie, B. D., Mara, K. C., Harmsen, W. S., Dai, J., Zhang, N., Wongjarupong, N., Ali, H. M., Ali, H. A., Hassan, F. A., et al. (2019) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-18-0281 · Cited by 222
Riaz, A., Ryu, R. K., Kulik, L. M., Mulcahy, M. F., Lewandowski, R. J., Minocha, J., Ibrahim, S. M., Sato, K. T., Baker, T., Miller, F. H., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.1282 · Cited by 220
Ma, X., Wei, J., Gu, D., Zhu, Y., Feng, B., Liang, M., Wang, S., Zhao, X., & Tian, J. (2019) · European Radiology · doi:10.1007/s00330-018-5985-y · Cited by 219
Personeni, N., Bozzarelli, S., Pressiani, T., Rimassa, L., Tronconi, M. C., Sclafani, F., Carnaghi, C., Pedicini, V., Giordano, L., & Santoro, A. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.02.016 · Cited by 210
Clinical Impact of Genomic Diversity From Early to Advanced Hepatocellular Carcinoma
Nault, J., Martin, Y., Caruso, S., Hirsch, T. Z., Bayard, Q., Calderaro, J., Charpy, C., Copie‐Bergman, C., Ziol, M., Bioulac‐Sage, P., et al. (2020) · Hepatology · doi:10.1002/hep.30811 · Cited by 207
Choi, J., Kim, G., Han, S., Lee, W., Chun, S., & Lim, Y. (2019) · Hepatology · doi:10.1002/hep.30233 · Cited by 205
Biomarkers Associated With Response to Regorafenib in Patients With Hepatocellular Carcinoma
Teufel, M., Seidel, H., Köchert, K., Meinhardt, G., Finn, R. S., Llovet, J. M., & Bruix, J. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.01.261 · Cited by 202
Park, J.-W., Kim, Y. J., Kim, D. Y., Bae, S.-H., Paik, S. W., Lee, Y.-J., Kim, H. Y., Lee, H. C., Han, S. Y., Cheong, J. Y., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.11.029 · Cited by 198
Diagnostic accuracy of tumor markers for hepatocellular carcinoma: a systematic review
Tateishi, R., Yoshida, H., Matsuyama, Y., Mine, N., Kondo, Y., & Omata, M. (2008) · Hepatology International · doi:10.1007/s12072-007-9038-x · Cited by 194
Yamamoto, K., Imamura, H., Matsuyama, Y., Kume, Y., Ikeda, H., Norman, G. L., Shums, Z., Aoki, T., Hasegawa, K., Beck, Y., et al. (2010) · Journal of Gastroenterology · doi:10.1007/s00535-010-0278-5 · Cited by 190
Tremosini, S., Forner, A., Boix, L., Vilana, R., Bianchi, L., Reig, M., Rimola, J., Rodríguez-Lope, C., Ayuso, C., Solé, M., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-301862 · Cited by 188
Serum microRNA-1 and microRNA-122 are prognostic markers in patients with hepatocellular carcinoma
Köberle, V., Kronenberger, B., Pleli, T., Trojan, J., Imelmann, E., Peveling-Oberhag, J., Welker, M.-W., Elhendawy, M., Zeuzem, S., Piiper, A., et al. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.06.002 · Cited by 184
Epidemiology and Surveillance of Hepatocellular Carcinoma
Kim, D. Y., & Han, K.-H. (2012) · Liver Cancer · doi:10.1159/000339016 · Cited by 181
El-Serag, H. B., Kanwal, F., Davila, J. A., Kramer, J., & Richardson, P. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.01.045 · Cited by 181
Shiraki, K., Takase, K., Tameda, Y., HAMADA, M., Kosaka, Y., & Nakano, T. (1995) · Hepatology · doi:10.1002/hep.1840220317 · Cited by 180
Durazo, F. A., Blatt, L. M., Corey, W. G., Lin, J., Han, S., Saab, S., Busuttil, R. W., & Tong, M. J. (2008) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2008.05395.x · Cited by 177
Taketomi, A., Sanefuji, K., Soejima, Y., Yoshizumi, T., Uhciyama, H., Ikegami, T., Harada, N., Yamashita, Y., Sugimachi, K., Kayashima, H., et al. (2009) · Transplantation · doi:10.1097/tp.0b013e3181943bee · Cited by 176
Yamashita, F., Tanaka, M., Satomura, S., & Tanikawa, K. (1996) · Gastroenterology · doi:10.1016/s0016-5085(96)70067-7 · Cited by 174
Shao, Y., Lin, Z., Hsu, C., Shen, Y., Hsu, C., & Cheng, A. (2010) · Cancer · doi:10.1002/cncr.25257 · Cited by 173
Fujiki, M., Takada, Y., Ogura, Y., Oike, F., Kaido, T., Teramukai, S., & Uemoto, S. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02783.x · Cited by 171
Nakamura, S., Nouso, K., Sakaguchi, K., Ito, Y. M., Ohashi, Y., Kobayashi, Y., Toshikuni, N., Tanaka, H., Miyake, Y., Matsumoto, E., et al. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00681.x · Cited by 166
Mehta, N., Dodge, J. L., Grab, J. D., & Yao, F. Y. (2020) · Hepatology · doi:10.1002/hep.30879 · Cited by 162
Feun, L. G., Li, Y., Wu, C., Wangpaichitr, M., Jones, P. D., Richman, S. P., Madrazo, B., Kwon, D., Garcia‐Buitrago, M., Martin, P., et al. (2019) · Cancer · doi:10.1002/cncr.32339 · Cited by 160
Met as a therapeutic target in HCC: Facts and hopes
Giordano, S., & Columbano, A. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.09.009 · Cited by 158
Tateishi, R., Shiina, S., Yoshida, H., Teratani, T., Obi, S., Yamashiki, N., Yoshida, H., Akamatsu, M., Kawabe, T., & Omata, M. (2006) · Hepatology · doi:10.1002/hep.21408 · Cited by 154
Mehta, N. J., Dodge, J. L., Goel, A., Roberts, J. P., Hirose, R., & Yao, F. Y. (2013) · Liver Transplantation · doi:10.1002/lt.23753 · Cited by 154
Wong, R. J., Ahmed, A., & Gish, R. G. (2015) · Clinics in Liver Disease · doi:10.1016/j.cld.2015.01.005 · Cited by 153
Trinchet, J., Bourcier, V., Chaffaut, C., Ait‐Ahmed, M., Allam, S., Marcellin, P., Guyader, D., Pol, S., Larrey, D. G., de Lédinghen, V., et al. (2015) · Hepatology · doi:10.1002/hep.27743 · Cited by 148
Volk, M. L., Hernandez, J. C., Su, G. L., Lok, A. S.-F., & Marrero, J. A. (2007) · Cancer Biomarkers · doi:10.3233/cbm-2007-3202 · Cited by 147
Leerapun, A., Suravarapu, S. V., Bida, J. P., Clark, R. J., Sanders, E. L., Mettler, T. A., Stadheim, L. M., Aderca, I., Moser, C. D., Nagorney, D. M., et al. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.12.005 · Cited by 138
Yao, Z., Dong, Y., Wu, G., Zhang, Q., Yang, D., Yu, J., & Wang, W. (2018) · BMC Cancer · doi:10.1186/s12885-018-5003-4 · Cited by 136
Suehiro, T., Sugimachi, K., Matsumata, T., Itasaka, H., Taketomi, A., & Maeda, T. (1994) · Cancer · doi:10.1002/1097-0142(19940515)73:10<2464::aid-cncr2820731004>3.0.co;2-9 · Cited by 135
EASL and AASLD recommendations for the diagnosis of HCC to the test of daily practice
Aubé, C., Oberti, F., Lonjon, J., Pageaux, G., Séror, O., Nkontchou, G., Rode, A., Radenne, S., Cassinotto, C., Vergniol, J., et al. (2017) · Liver International · doi:10.1111/liv.13429 · Cited by 134
Staging Hepatocellular Carcinoma by a Novel Scoring System (BALAD Score) Based on Serum Markers
Toyoda, H., Kumada, T., Osaki, Y., Oka, H., Urano, F., Kudo, M., & Matsunaga, T. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.09.021 · Cited by 132
Iavarone, M. A., Cabibbo, G., Biolato, M., Corte, C. D., Maida, M. F., Barbàra, M., Basso, M., Vavassori, S., Craxì, A., Grieco, A., et al. (2015) · Hepatology · doi:10.1002/hep.27729 · Cited by 132
Raoul, J., Bruix, J., Greten, T. F., Sherman, M., Mazzaferro, V., Hilgard, P. A., Scherübl, H., Scheulen, M. E., Germanidis, G. S., Dominguez, S., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.12.009 · Cited by 131
Chen, V. L., Xu, D., Wicha, M. S., Lok, A. S.-F., & Parikh, N. D. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.04.019 · Cited by 125
Chaiteerakij, R., Zhang, X., Addissie, B. D., Mohamed, E. A., Harmsen, W. S., Theobald, P. J., Peters, B. E., Balsanek, J. G., Ward, M. M., Giama, N. H., et al. (2015) · Liver Transplantation · doi:10.1002/lt.24117 · Cited by 124
Clinical Utility of AFP-L3% Measurement in North American Patients with HCV-Related Cirrhosis
Sterling, R. K., Jeffers, L. J., Gordon, F. D., Sherman, M., Venook, A. P., Reddy, K. R., Satomura, S., & Schwartz, M. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01405.x · Cited by 122
Sterling, R. K., Wright, E. C., Morgan, T. R. M., et al. (2011) · The American Journal of Gastroenterology · doi:10.1038/ajg.2011.312 · Cited by 121
Wu, J., Liu, A., Cui, J., Chen, A., Song, Q., & Xie, L. (2019) · BMC Medical Imaging · doi:10.1186/s12880-019-0321-9 · Cited by 115
Bayo, J., Fiore, E. J., Domínguez, L. M., Real, A., Malvicini, M., Rizzo, M., Atorrasagasti, C., García, M. G., Argemí, J., Martínez, E. D., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.03.007 · Cited by 113
Toyoda, H., Kumada, T., Kiriyama, S., Sone, Y., Tanikawa, M., Hisanaga, Y., Yamaguchi, A., Isogai, M., Kaneoka, Y., & Washizu, J. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(05)00855-4 · Cited by 110
Association between PD1 mRNA and response to anti-PD1 monotherapy across multiple cancer types
Paré, L., Pascual, T., Seguí, E., Teixidó, C., González‐Cao, M., Galván, P., Rodríguez, A., González‐Farré, B., Cuatrecasas, M., Pineda, E., et al. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy335 · Cited by 107
Yamamoto, K., Imamura, H., Matsuyama, Y., Hasegawa, K., Beck, Y., Sugawara, Y., Makuuchi, M., & Kokudo, N. (2009) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0618-y · Cited by 106
New Serum Markers of Hepatocellular Carcinoma
Masuzaki, R., Karp, S. J., & Omata, M. (2012) · Seminars in Oncology · doi:10.1053/j.seminoncol.2012.05.009 · Cited by 103
Circulating Microbiota-Based Metagenomic Signature for Detection of Hepatocellular Carcinoma
Cho, E. J., Leem, S., Kim, S. A., Yang, J., Lee, Y. B., Kim, S. S., Cheong, J. Y., Cho, S. W., Kim, J. W., Kim, S., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-44012-w · Cited by 103
Ji, J., Wang, H., Li, Y., Zheng, L., Yin, Y., Zou, Z., Zhou, F., Zhou, W., Shen, F., & Gao, C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153227 · Cited by 101
Mazziotti, G., Sorvillo, F., Morisco, F., Carbone, A., Rotondi, M., Stornaiuolo, G., Precone, D. F., Cioffi, M., Gaeta, G. B., Caporaso, N., et al. (2002) · Cancer · doi:10.1002/cncr.11002 · Cited by 99
Tayob, N., Lok, A. S.-F., Do, K.-A., & Feng, Z. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.07.049 · Cited by 98
Montal, R., Andreu-Oller, C., Bassaganyas, L., Esteban-Fabró, R., Morán, S., Montironi, C., Moeini, A., Pinyol, R., Peix, J., Cabellos, L., et al. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0513-7 · Cited by 97
Piñero, F., Baña, M. T., de Ataíde, E. C., Duque, S. H., Marciano, S., Varón, A., Anders, M., Zerega, A. R., Menéndez, J., Zapata, R., et al. (2016) · Liver International · doi:10.1111/liv.13159 · Cited by 92
Self-citationGuo, X., Lv, X., Lv, X., Ma, Y., Chen, L., & Chen, Y. (2017) · Oncotarget · doi:10.18632/oncotarget.17211 · Cited by 87
Santoro, A., Simonelli, M., de Lope, C. R., Zucali, P. A., Camacho, L. H., Granito, A., Senzer, N. N., Rimassa, L., Abbadessa, G., Schwartz, B. E., et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2012.556 · Cited by 81
Biselli, M., Conti, F., Gramenzi, A., Frigerio, M., Cucchetti, A., Fatti, G., D’Angelo, M., Dall’Agata, M., Giannini, E. G., Farinati, F., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.536 · Cited by 80
Mendizábal, M., Piñero, F., Ridruejo, E., Wolff, F. H., Anders, M., Reggiardo, V., Ameigeiras, B., Palazzo, A., Alonso, C., Schinoni, M. I., et al. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.02.044 · Cited by 79
Self-citationSinha, J., Mehta, N. J., Dodge, J. L., Poltavskiy, E. A., Roberts, J. P., & Yao, F. Y. (2019) · Hepatology · doi:10.1002/hep.30570 · Cited by 78
(2019) · doi:10.1016/j.aohep.2018.10.003 · Cited by 77
Ponziani, F. R., Nicoletti, A., Gasbarrini, A., & Pompili, M. (2019) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835919848184 · Cited by 73
Vitale, A., D’Amico, F., Frigo, A. C., Grigoletto, F., Brolese, A., Zanus, G., Neri, D., Carraro, A., D’Amico, F. E., Burra, P., et al. (2010) · Annals of Surgical Oncology · doi:10.1245/s10434-010-0993-4 · Cited by 66
Biomarker-based prognosis in hepatocellular carcinoma: validation and extension of the BALAD model
Fox, R., Berhane, S., Teng, M. J., Cox, T. F., Tada, T., Toyoda, H., Kumada, T., Kagebayashi, C., Satomura, S., & Johnson, P. J. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.130 · Cited by 65
Kodama, K., Kawaoka, T., Namba, M., Uchikawa, S., Ohya, K., Morio, K., Nakahara, T., Murakami, E., Yamauchi, M., Hiramatsu, A., et al. (2019) · Oncology · doi:10.1159/000499715 · Cited by 58
Prognostic significance of glypican-3 expression in hepatocellular carcinoma
Liu, H., Yang, C., Lu, W., & Zeng, Y. (2018) · Medicine · doi:10.1097/md.0000000000009702 · Cited by 49
The clinical course of cirrhosis. Population based studies and the need of personalized medicine
D’Amico, G. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.10.023 · Cited by 46
Circulating Tumor DNA and Hepatocellular Carcinoma
Yang, J. D., Liu, M., & Kisiel, J. B. (2019) · Seminars in Liver Disease · doi:10.1055/s-0039-1688503 · Cited by 46
Differences in the impact of prognostic factors for hepatocellular carcinoma over time
Toyoda, H., Kumada, T., Tada, T., Yama, T., Mizuno, K., Sone, Y., Maeda, A., Kaneoka, Y., Akita, T., & Tanaka, J. (2017) · Cancer Science · doi:10.1111/cas.13406 · Cited by 42
Kim, A., Shim, S., Kim, M., Myung, J. K., & Park, S. (2018) · Scientific Reports · doi:10.1038/s41598-018-27666-w · Cited by 38
The Liver Cancer Study Group of Japan, Toyoda, H., Tada, T., Johnson, P. J., Izumi, N., Kadoya, M., Kaneko, S., Kokudo, N., Ku, Y., Kubo, S., et al. (2017) · Journal of Gastroenterology · doi:10.1007/s00535-017-1321-6 · Cited by 33
Surveillance for hepatocellular carcinoma
Díaz‐González, Á., & Forner, A. (2016) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2016.10.006 · Cited by 31
Finn, R. S., Kudo, M., Cheng, A., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx440.022 · Cited by 14
Piñero, F., Rubinstein, F., Marciano, S., Fernández, N., Silva, J. M. R., Zambelo, Y., Anders, M., Zerega, A. R., Ridruejo, E., Míguez, C., et al. (2018) · Digestive Diseases and Sciences · doi:10.1007/s10620-018-5390-z · Cited by 10
Self-citation
Cited by
Yang, Z., Tian, T., Kong, J., & Chen, H. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.4c06677 · Cited by 46
Metadata
- Authors
- Piñero, F., Dirchwolf, M., & Pessôa, M. G.
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2020-06-01
- Volume
- 9
- Issue
- 6
- Pages
- 1370
- ISSN
- 2073-4409 (ISSN-L)
- OpenAlex
- W3030956000
- Cited by
- 498
- References
- 158
- FWCI
- 33.47
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.